Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$8.87 - $22.1 $2.13 Million - $5.3 Million
-240,000 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$10.79 - $22.87 $3.14 Million - $6.65 Million
-290,581 Reduced 54.77%
240,000 $5.49 Million
Q1 2021

May 14, 2021

SELL
$11.8 - $23.11 $351,392 - $688,192
-29,779 Reduced 5.31%
530,581 $6.99 Million
Q4 2020

Feb 11, 2021

BUY
$15.12 - $25.88 $8.47 Million - $14.5 Million
560,360 New
560,360 $11.4 Million

Others Institutions Holding FHTX

About Foghorn Therapeutics Inc.


  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $326M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.